Peripheral Vascular Disease Medical Slides
Generate publication-quality peripheral vascular disease lecture slides in 30 seconds. AI-powered content structured for clinical education.
Generate Peripheral Vascular Disease DeckWhy teach Peripheral Vascular Disease?
Peripheral arterial disease affects over 200 million people worldwide, with prevalence exceeding 20% in adults over 70. The ankle-brachial index (ABI) is the primary diagnostic tool, with values ≤0.90 diagnostic for PAD. Despite its high cardiovascular morbidity (2-4 fold increased MI and stroke risk), PAD remains underdiagnosed and undertreated. The CLEVER trial demonstrated that supervised exercise therapy matched revascularization for claudication outcomes, and the BEST-CLI trial (2022) provided landmark evidence comparing surgical bypass versus endovascular intervention for chronic limb-threatening ischemia.
What AI generates for Peripheral Vascular Disease
Enter “Peripheral Vascular Disease” and SlideCraft generates a complete lecture deck with slides like these.
See it in action
Type any medical topic and watch AI generate a presentation slide in seconds. No signup required.
3 free previews per hour · No account needed
Enter a topic and click Generate to see your AI slide
Peripheral Vascular Disease Presentation FAQ
How should the BEST-CLI trial be presented in PAD teaching?
Present the BEST-CLI trial (2022, NEJM): 1830 CLTI patients randomized to surgical bypass-first versus endovascular-first strategy. In patients with adequate saphenous vein (cohort 1): bypass was superior with significantly fewer major adverse limb events and death (42.6% vs 57.4% at median 2.7 years). In patients without adequate vein (cohort 2): no significant difference between prosthetic bypass and endovascular. Teaching message: for CLTI with adequate single-segment great saphenous vein, surgical bypass is the preferred revascularization strategy. Endovascular-first is appropriate when adequate vein is absent, when bypass targets are poor, or when patient comorbidities make bypass high-risk.
What supervised exercise therapy evidence should be highlighted for claudication?
Present the CLEVER trial (2012): supervised exercise therapy (SET) vs endovascular revascularization vs optimal medical care for aortoiliac claudication. At 6 months: SET improved peak walking time equally to stenting and significantly more than medical therapy alone. At 18 months: SET was superior to stenting for peak walking time. AHA/ACC guidelines recommend SET as first-line therapy for claudication (Class 1 recommendation). Protocol: 30-50 minutes of treadmill walking 3×/week for ≥12 weeks, walking to near-maximal claudication pain then resting, progressive intensity. Barriers: insurance coverage (Medicare covers SET since 2017), program availability, patient compliance.
How should the WIfI classification be taught for CLTI?
Present the SVS WIfI (Wound, Ischemia, and Foot Infection) classification system: W (Wound) — grade 0-3 by depth and location. I (Ischemia) — grade 0-3 by ABI, ankle pressure, toe pressure, and TcPO2. fI (Foot Infection) — grade 0-3 by IDSA/IWGDF criteria. Combined WIfI stage (1-4) predicts 1-year amputation risk: Stage 1 (very low, ~5%), Stage 2 (low, ~10%), Stage 3 (moderate, ~25%), Stage 4 (high, ~40%). Clinical utility: guides urgency of revascularization, helps identify patients who need urgent vascular consultation (WIfI stage ≥3), and provides a common language for multidisciplinary limb salvage teams (vascular surgery, podiatry, infectious disease, wound care).
Simple pricing, no surprises
Start free today. Upgrade when your department needs more.
Free
Try SlideCraft with no commitment
- 2 decks per month
- AI slides with speaker notes
- View & present only (no export)
- 7-day cloud storage
- Slide Checker & Outline Generator
Pro
For clinicians who lecture weekly
- 10 decks/mo + $2.50/extra
- AI Critic Mode (5-axis review)
- Document-to-deck (PDF upload)
- PDF, PPTX, SCORM & image export
- Permanent cloud storage
Expert
For academic physicians who publish and present
- 25 decks/mo + $2.00/extra
- PubMed source verification
- Paper-to-deck pipeline
- Auto-citations (Vancouver)
- Everything in Pro